Role of ciprofloxacin in its synergistic effect with fosfomycin on drug-resistant strains of Pseudomonas aeruginosa

Chemotherapy

Volumn 53, Issue 3, 2007, Pages 202-209

  Yamada, Sakuo ^a   Hyo, Yukiyoshi ^a   Ohmori, Sachiyo ^a   Ohuchi, Masanobu ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Ciprofloxacin; Electron microscopy; Fosfomycin; Pseudomonas aeruginosa

Indexed keywords

CIPROFLOXACIN; FOSFOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIOLYSIS; CONTROLLED STUDY; DRUG POTENTIATION; EXPERIMENTAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MORPHOLOGY; NONHUMAN; OUTER MEMBRANE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TURBIDITY;

ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; DRUG SYNERGISM; FOSFOMYCIN; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, TRANSMISSION; PSEUDOMONAS AERUGINOSA;

EID: 34147214218     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000100811     Document Type: Article

References (29)

1. Korvick JA, Yu VL: Antimicrobial agent therapy for Pseudomonas aeruginosa. Antimicrob Agents Chemother 1991;35:2167-2172.
2. Bingen E, Bonacorsi S, Rohrlich P, Duval M, Lhopital S, Brahimi N, Vilmer E, Goering RV: Molecular epidemiology provides evidence of genotypic heterogeneity of multidrug-resistant Pseudomonas aeruginosa serotype O:12 outbreak isolates from a pediatric hospital. J Clin Microbiol 1996;34:3226-3229.
3. Piddock LJV: Mechanisms of fluoroquinolone resistance: an update 1994-1998. Drugs 1999;58(suppl 2):11-18.
4. Poole K: Bacterial multidrug resistance - emphasis on efflux mechanisms and Pseudomonas aeruginosa. J Antimicrob Chemother 1994;34:453-456.
5. Wiedemann B, Heisig P: Quinolone resistance in Gram-negative bacteria. Infect Dis Clin Pract 1994;3(suppl 3):S115-S124.
6. Coban AY, Ekinci B, Durupinar B: A multidrug efflux pump inhibitor reduces fluoroquinolone resistance in Pseudomonas aeruginosa isolates. Chemotherapy 2004;50:22-26.
7. Drago G, Vecchi ED, Nicola L, Colombo A, Guerra A, Gismondo MR: Activity of levofloxacin and ciprofloxacin in combination with cefepime, ceftazidime, imipenem, piperacillin-tazobactam and amikacin against different Pseudomonas aeruginosa phenotypes and Actinetobacter spp. Chemotherapy 2004;50:202-210.
8. Figueredo VM, Neu HC: Synergy of ciprofloxacin with fosfomycin in vitro against Pseudomonas isolates from patients with cystic fibrosis. J Antimicrob Chemother 1988;22:41-50.
9. Haller I: Comprehensive evaluation of ciprofloxacin-aminoglycoside combinations against Enterobacteriaceae and Pseudomonas aeruginosa strains. Antimicrob Agents Chemother 1985;28:663-666.
10. Neu HC: Synergy of fluoroquinolones with other antimicrobial agents. Rev Infect Dis 1989;11:S1025-S1035.
11. Tessier F, Quentin C: In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis 1997;16:159-162.
12. Xiong YQ, Potel G, Caillon J, Stephant G, Jehl F, Bugnon D, Conte PL, Baron D, Drugeon H: Comparative efficacies of ciprofloxacin and pefloxacin alone or in combination with fosfomycin in experimental endocarditis induced by multidrug-susceptible and - resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 1995;39:496-499.
13. Gellert M, Mizuuchi K, O'Dea MH, Itoh T, Tomizawa J: Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity. Proc Natl Acad Sci USA 1997;74:4772-4776.
14. Hooper DC: Quinolone mode of action. Drugs 1995;49:10-15.
15. Kahan FM, Kahan JS, Cassidy PJ, Kropp H: The mechanism of action of fosfomycin (phosphonomycin). Ann NY Acad Sci 1974;235:364-386.
16. Okuhara M, Kuroda Y, Goto T, Okamoto M, Terano H, Kohsaka M, Aoki H, Imanaka H: Studies on new phosphonic acid antibiotics. 1. FR-900098, isolation and characterization. J Antibiot 1979;33:13-17.
17. National Committee for Clinical Laboratory Standards: Performance Standards for Antimicrobial Susceptibility Testing - Fourteenth Informational Supplement M100-S14. Villanova, NCCLS, 2004.
18. Odds FC: Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 2003;52:1.
19. Sugai M, Yamada S, Nakashima S, Komatsuzawa H, Matsumoto A, Oshida T, Suginaka H: Localized perforation of the cell wall by a major autolysin: atl gene products and the onset of penicillin-induced lysis of Staphylococcus aureus. J Bacteriol 1997;179:2958-2962.
20. Yamada S, Matsumoto A: Localization of protein A on the cell surface of Staphylococcus aureus Cowan I and protein A-deficient strains. J Electron Microsc 1984;33:172-174.
21. Yamada S, Sugai M, Komatsuzawa H, Nakashima S, Oshida T, Matsumoto A, Suginaka H: An autolysin ring associated with cell separation of Staphylococcus aureus. J Bacteriol 1996;178:1565-1571.
22. Voigt WH, Zeiler HJ: Influence of ciprofloxacin on the ultrastructure of Gram-negative and Gram-positive bacteria. Arzneimittelforschung 1985;35:1600-1603.
23. Smith JT: Awakening the slumbering potential of the 4-quinolone antibacterials. Pharm J 1984;15:299-305.
24. Zeiler HJ: Evaluation of the in vitro bactericidal action of ciprofloxacin on cells of Escherichia coli in the logarithmic and stationary phases of growth. Antimicrob Agents Chemother 1985;28:524-527.
25. Elliott TSJ, Shelton A, Greenwood D: The response of Escherichia coli to ciprofloxacin and norfloxacin. J Med Microbiol 1987;23:83-88.
26. Tanaka M, Otsuki M, Nishino T: Bactericidal activities of ofloxacin and its optically active isomer (DR-3355) on non-growing cells of Escherichia coli and Pseudomonas aeruginosa. Chemotherapy 1992;38:21-27.
27. Kumon H, Ono N, Iida M, Nickel JC: Combination effect of fosfomycin and ofloxacin against Pseudomonas aeruginosa growing in a biofilm. Antimicrob Agents Chemother 1995;39:1038-1044.
28. Monden K, Ando E, Iida M, Kumon H: Role of fosfomycin in a synergistic combination with ofloxacin against Pseudomonas aeruginosa growing in a biofilm. J Infect Chemother 2002;8:218-226.
29. Vogt K, Hahn H: Synergism between ciprofloxacin and fosfomycin against Gram-negative bacteria in vitro. Zentralbl Bakteriol 1989;272:225-230.